SUN 09

Drug Profile

SUN 09

Alternative Names: B-09; Baclofen prodrug - Sun Pharma Advanced Research Company; SUN-09; SUN-B09

Latest Information Update: 21 Apr 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Sun Pharma Advanced Research Company
  • Class Aminobutyric acids; Antispastics; Muscle relaxants; Small molecules
  • Mechanism of Action GABA B receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Muscle spasticity

Most Recent Events

  • 25 Mar 2013 SUN 09 is under commercial evaluation with Sun Pharma Advanced Research Company
  • 31 Jan 2012 SUN 09 is still in phase I trials for Spasticity in India
  • 30 Jun 2011 Phase-I clinical trials in Spasticity in India (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top